These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12608148)

  • 1. Aggressive lipid reduction provides additional clinical benefit.
    Am J Manag Care; 2002 Jul; Suppl Symposium Reporter():1, 4. PubMed ID: 12608148
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholesterol--frequently asked questions.
    Phillips PJ; Phillipov G
    Aust Fam Physician; 2006 Aug; 35(8):595-6. PubMed ID: 16894432
    [No Abstract]   [Full Text] [Related]  

  • 3. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ask the doctor. I have been taking a statin to bring down my LDL cholesterol, but my HDL is still on the low side. Do I need to worry about my HDL level if my LDL is okay? If so, what should I do?
    Bhatt DL
    Harv Heart Lett; 2014 May; 24(9):2. PubMed ID: 25151665
    [No Abstract]   [Full Text] [Related]  

  • 5. The anti-thrombotic effects of statins.
    Kearney D; Fitzgerald D
    J Am Coll Cardiol; 1999 Apr; 33(5):1305-7. PubMed ID: 10193731
    [No Abstract]   [Full Text] [Related]  

  • 6. [Letter on the article: "Which lipid profiles and how to interpret in patients with coronary heart disease?"].
    Ambrosi P
    Presse Med; 2010 Feb; 39(2):286-7. PubMed ID: 20074902
    [No Abstract]   [Full Text] [Related]  

  • 7. Eicosapentaenoic acid for prevention of major coronary events.
    Colhoun HM
    Lancet; 2007 Jul; 370(9583):215. PubMed ID: 17658384
    [No Abstract]   [Full Text] [Related]  

  • 8. Underutilization of lipid-lowering therapy in coronary artery disease.
    Batalla A; Hevia S; Reguero JR; Cubero GI
    Arch Intern Med; 2000 Sep; 160(17):2683-4. PubMed ID: 10999994
    [No Abstract]   [Full Text] [Related]  

  • 9. Reports from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). HMG-CoA reductase inhibitors: a review of published clinical trials and pharmacoeconomic evaluations.
    Int J Technol Assess Health Care; 1998; 14(2):396-8. PubMed ID: 9678976
    [No Abstract]   [Full Text] [Related]  

  • 10. Statins and aortic stenosis in the context of ratio of low- to high-density lipoprotein cholesterol.
    Yilmaz MB
    J Am Coll Cardiol; 2007 Jul; 50(3):289-90; author reply 290. PubMed ID: 17631225
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of high blood cholesterol in patients with coronary heart disease].
    Nagai Y; Yamashita S
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():675-81. PubMed ID: 12735049
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms of disease: HDL metabolism as a target for novel therapies.
    Rader DJ
    Nat Clin Pract Cardiovasc Med; 2007 Feb; 4(2):102-9. PubMed ID: 17245404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?
    Fabbri G; Maggioni AP
    Adv Ther; 2009 May; 26(5):469-87. PubMed ID: 19444394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stricter cholesterol guidelines broaden indications for the 'statin' drugs.
    Capriotti T
    Medsurg Nurs; 2003 Feb; 12(1):51-7. PubMed ID: 12619600
    [No Abstract]   [Full Text] [Related]  

  • 15. Intensive cholesterol lowering: no longer a myth.
    Bitzur R; Harats D
    Isr Med Assoc J; 2005 Dec; 7(12):816-7. PubMed ID: 16382708
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapies for raising high-density lipoprotein cholesterol.
    Miura S; Saku K
    Intern Med; 2007; 46(7):339-40. PubMed ID: 17409593
    [No Abstract]   [Full Text] [Related]  

  • 17. Statin therapy: more than meets the eye?
    McCain J
    Manag Care; 2004 Apr; 13(4):40-9. PubMed ID: 15146720
    [No Abstract]   [Full Text] [Related]  

  • 18. Rationale for aggressive lipid lowering: evidence from clinical trials.
    Farmer JA
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):305-9. PubMed ID: 15151477
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimizing statin drug therapy.
    Ramsey LA; Miles AJ
    Adv Nurse Pract; 2002 Mar; 10(3):27-8. PubMed ID: 12418333
    [No Abstract]   [Full Text] [Related]  

  • 20. Vascular disease, hypertension, and prevention.
    Lavie CJ
    J Am Coll Cardiol; 2004 Jul; 44(2 Suppl A):19A-22A. PubMed ID: 15261686
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.